Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology

Fig. 1

Proportion of patients with no, newly diagnosed and known diabetes prescribed the different cardioprotective drugs alone and in combination. Renin–angiotensin–aldosterone–system (RAAS)-blockers includes angiotensin converting enzyme inhibitors and angiotensin receptor blockers. ASA aspirin. All 4 = the combination of aspirin (or other anticoagulants) + a β-blocker + a RAAS-blocker and a statin. *p < 0.0001

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840